Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)

In the last French study in 2007, the incidence of hospital admissions (HAs) related to adverse drug reactions (ADRs) was 3.6%. The objective was to assess the current ADR‐HA incidence in France and to describe both its characteristics and preventability.

[1]  P. Glassman,et al.  Estimated Costs of Severe Adverse Drug Reactions Resulting in Hospitalization in the Veterans Health Administration , 2022, JAMA network open.

[2]  J. Cracowski,et al.  Prevention of risks associated with inappropriate use/unnecessary consumption of medicines , 2022, Therapies.

[3]  S. Davani,et al.  Epidemiology and economic burden of ‘serious’ adverse drug reactions: real-world evidence research based on pharmacovigilance data , 2021, Therapies.

[4]  M. Niemi,et al.  Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department , 2020, European journal of clinical pharmacology.

[5]  E. Oger,et al.  Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study , 2020, PloS one.

[6]  E. Oger,et al.  Major bleeding risk associated with oral anticoagulant in real clinical practice. A multicentre 3‐year period population‐based prospective cohort study , 2020, British journal of clinical pharmacology.

[7]  M. Briet,et al.  Drug interactions related to self‐medication: a French pharmacovigilance database study , 2020, Fundamental & clinical pharmacology.

[8]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets , 2019, British journal of pharmacology.

[9]  M. Ayalew,et al.  Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures , 2019, Bulletin of emergency and trauma.

[10]  N. Glasgow,et al.  Trends in adverse drug reaction‐related hospitalisations over 13 years in New South Wales, Australia , 2019, Internal medicine journal.

[11]  V. Naik,et al.  Hospitalizations due to preventable adverse reactions—a systematic review , 2017, European Journal of Clinical Pharmacology.

[12]  T. Vial.  French pharmacovigilance: Missions, organization and perspectives. , 2016, Therapie.

[13]  M. Koopmanschap,et al.  Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies , 2015, Drug Safety.

[14]  Françoise Haramburu,et al.  Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study , 2015, Fundamental & clinical pharmacology.

[15]  H. Aljadhey,et al.  A systematic review of hospitalization resulting from medicine‐related problems in adult patients , 2014, British journal of clinical pharmacology.

[16]  M. Petzold,et al.  Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults , 2013, British journal of clinical pharmacology.

[17]  Jeannot Schmidt,et al.  Frequency and Severity of Adverse Drug Reactions Due to Self-Medication: A Cross-Sectional Multicentre Survey in Emergency Departments , 2013, Drug Safety.

[18]  Azeem Majeed,et al.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.

[19]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[20]  H. Beijer,et al.  Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies , 2002, Pharmacy World and Science.

[21]  B Bégaud,et al.  Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France , 1985 .

[22]  J. Mckenney,et al.  Drug-related hospital admissions. , 1976, American journal of hospital pharmacy.

[23]  B. Giraudeau,et al.  Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre , 2009, Drug safety.

[24]  J Jouglard,et al.  [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. , 1985, Therapie.